Intuitive Surgical, Inc. $ISRG Shares Acquired by Lord Abbett & CO. LLC

Key Points

• Lord Abbett & Co. LLC dramatically boosted its stake in Intuitive Surgical in the fourth quarter, adding about 200,669 shares and bringing its holdings to 201,276 shares worth roughly $114 million.
• Intuitive Surgical recently posted strong quarterly results, with EPS of $2.50 beating estimates and revenue of $2.77 billion rising 23% year over year. The company also remains highly profitable, with a net margin of 28.15%.
• Despite solid fundamentals, the stock has pulled back, trading near $411.06 versus a 52-week high of $603.88. Analysts remain broadly positive overall, though several have trimmed price targets and the consensus rating is still Moderate Buy.

Lord Abbett & CO. LLC increased its position in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 33,059.1% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 201,276 shares of the medical equipment provider's stock after acquiring an additional 200,669 shares during the period. Lord Abbett & CO. LLC owned approximately 0.06% of Intuitive Surgical worth $113,995,000 at the end of the most recent reporting period.

A number of other large investors have also modified their holdings of ISRG. Holos Integrated Wealth LLC acquired a new stake in shares of Intuitive Surgical in the 4th quarter worth about $25,000. Newbridge Financial Services Group Inc. increased its holdings in shares of Intuitive Surgical by 300.0% in the 4th quarter. Newbridge Financial Services Group Inc. now owns 44 shares of the medical equipment provider's stock worth $25,000 after acquiring an additional 33 shares during the period. Olistico Wealth LLC acquired a new stake in shares of Intuitive Surgical in the 4th quarter worth about $28,000. Caitlin John LLC acquired a new stake in shares of Intuitive Surgical in the 3rd quarter worth about $30,000. Finally, Laurel Wealth Advisors LLC acquired a new stake in shares of Intuitive Surgical in the 4th quarter worth about $31,000. Institutional investors and hedge funds own 83.64% of the company's stock.

Intuitive Surgical Trading Down 0.4%

NASDAQ:ISRG opened at $411.06 on Friday. Intuitive Surgical, Inc. has a twelve month low of $396.68 and a twelve month high of $603.88. The company has a 50-day moving average of $442.88 and a 200-day moving average of $496.19. The firm has a market cap of $145.58 billion, a price-to-earnings ratio of 49.83, a price-to-earnings-growth ratio of 3.30 and a beta of 1.46.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last posted its quarterly earnings data on Tuesday, April 21st. The medical equipment provider reported $2.50 earnings per share for the quarter, beating the consensus estimate of $2.08 by $0.42. Intuitive Surgical had a net margin of 28.15% and a return on equity of 15.98%. The company had revenue of $2.77 billion during the quarter, compared to analyst estimates of $2.62 billion. During the same quarter last year, the firm posted $1.81 EPS. The business's revenue for the quarter was up 23.0% on a year-over-year basis. On average, research analysts forecast that Intuitive Surgical, Inc. will post 8.57 earnings per share for the current year.

Insider Activity

In other news, SVP Iman Jeddi sold 5,625 shares of the firm's stock in a transaction dated Monday, June 1st. The shares were sold at an average price of $420.55, for a total transaction of $2,365,593.75. Following the completion of the transaction, the senior vice president owned 6,463 shares in the company, valued at approximately $2,718,014.65. This trade represents a 46.53% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Amy L. Ladd sold 500 shares of the firm's stock in a transaction dated Tuesday, April 28th. The shares were sold at an average price of $473.46, for a total transaction of $236,730.00. Following the transaction, the director owned 239 shares of the company's stock, valued at approximately $113,156.94. This trade represents a 67.66% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last quarter, insiders sold 7,169 shares of company stock worth $3,059,135. Corporate insiders own 0.60% of the company's stock.

Analysts Set New Price Targets

A number of research firms recently weighed in on ISRG. Truist Financial dropped their price objective on shares of Intuitive Surgical from $650.00 to $580.00 and set a "buy" rating on the stock in a report on Wednesday, April 15th. Piper Sandler reaffirmed an "overweight" rating and issued a $580.00 price objective on shares of Intuitive Surgical in a report on Tuesday, June 2nd. Leerink Partners dropped their price objective on shares of Intuitive Surgical from $622.00 to $573.00 and set an "outperform" rating on the stock in a report on Wednesday, April 22nd. TD Cowen decreased their target price on shares of Intuitive Surgical from $660.00 to $585.00 and set a "buy" rating for the company in a research report on Wednesday, April 22nd. Finally, UBS Group decreased their target price on shares of Intuitive Surgical from $570.00 to $550.00 and set a "neutral" rating for the company in a research report on Tuesday, March 17th. Nineteen equities research analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, the company currently has an average rating of "Moderate Buy" and an average target price of $571.28.

Key Headlines Impacting Intuitive Surgical

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: Analyst coverage remains broadly constructive, with brokerage sentiment still at a “Moderate Buy” and recent EPS estimate increases signaling confidence in Intuitive Surgical’s growth outlook.
• Positive Sentiment: Recent commentary highlights that the company’s scale, cost discipline, and adoption of the da Vinci 5 platform could help protect margins even if tariffs and input costs remain a concern.
• Neutral Sentiment: Investor attention has increased around ISRG, which can support trading activity, but this appears more like watchlist interest than a fresh business catalyst.
• Neutral Sentiment: BofA trimmed its price target slightly to $515 from $520, which still implies upside but signals a bit less optimism than before. Article: BofA adjusts price target on Intuitive Surgical to $515 from $520
• Neutral Sentiment: Two executives sold shares under pre-arranged 10b5-1 plans, including EVP Gary Loeb and EVP Mark Brosius. The sales were relatively small and routine, so they are unlikely to be a major fundamental concern.
• Negative Sentiment: One recent research note was notably bearish, with Deutsche Bank cutting its target to $366 and maintaining a sell rating, reinforcing concerns that valuation may still be too rich despite the company’s strong operating performance.
• Negative Sentiment: Seeking Alpha published a view calling Intuitive Surgical an “excellent business, unattractive stock,” reflecting ongoing investor caution around the valuation. Article: Intuitive Surgical: Excellent Business, Unattractive Stock

Intuitive Surgical Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon's hand movements into finer, scaled motions of small instruments inside the patient. Intuitive's business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.

Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.